Helius Medical Technologies, Inc. provided revenue guidance for the fourth quarter 2022. for the quarter, the company expects revenue to be modestly above the third quarter levels, factoring in the timing required to pair patients with trained physical therapists. In addition, as the company near the end of the fourth quarter, the company may experience some patients delaying PoNS treatment until after the holidays, which could temper sales growth as the company expand its U.S. market penetration.

As the company continue to build momentum and expand its sales coverage, the Company expects future quarterly revenue to continue increasing sequentially quarter over quarter throughout 2023 as the U.S. commercialization of PoNS develops.